A curated reading list of authoritative medical research, drug-safety databases, and focused analysis for researchers, patients, and advocates.
Reglan Tardive Dyskinesia settlement criteria explained: A Detailed Overview — detailed background and analysis.
Reference: U.S. Food and Drug Administration (FDA)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: European Medicines Agency (EMA)
Authoritative source for clinical, regulatory, and public-health background reading.